CSPC Pharmaceutical Group Limited. Profit Margin

CSPC Pharmaceutical Group Limited. (CSPCY) currently reports a profit margin of 12.76% as of December 2025. That compares with 18.71% in the prior-year period — down 31.8% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore CSPC Pharmaceutical Group Limited.'s profit margin history and peer comparisons.

CSPC Pharmaceutical Group Limited.'s profit margin decreased from 18.71% to 12.76% — a 31.8% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CSPC Pharmaceutical Group Limited.'s profit margin of 12.76% is lower than the Healthcare sector average of 15.29%. That is roughly 16.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but CSPC Pharmaceutical Group Limited.'s current 12.76% should be judged against Healthcare norms (sector average: 15.29%) and against CSPCY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 12.76%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for CSPC Pharmaceutical Group Limited., and consider following CSPCY for alerts when major investors trade the stock.